You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Apellis Pharmaceuticals
since
auto-detected in 1 stories
13 days ago
Biogen has agreed to acquire Apellis Pharmaceuticals for about $5.6 billion in cash, expanding its portfolio of rare-disease medicines.
page 1 of 1